Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sandra Mangold‐Gehring"'
Autor:
Annette Boegel, Ingo Flamme, Ralph Krebber, Terry Settje, Franziska Schmidt, Eva Kruedewagen, Sandra Mangold‐Gehring, Chantal Lainesse, Andreas Moritz, Gerald Beddies
Publikováno v:
Journal of Veterinary Internal Medicine, Vol 38, Iss 1, Pp 381-387 (2024)
Abstract Background Inhibition of hypoxia‐inducible factor prolyl hydroxylase (HIF‐PH) stimulates erythropoiesis in rats, dogs, monkeys, and humans. Hypothesis/Objective Determine if molidustat, a novel HIF‐PH inhibitor, stimulates erythropoies
Externí odkaz:
https://doaj.org/article/5ee4e2a0e7944511a886c3e34d6dc0c4
Autor:
Lea Heuer, Gabriele Petry, Matthias Pollmeier, Roland Schaper, Katrin Deuster, Holger Schmidt, Katrin Blazejak, Christina Strube, Angela Di Cesare, Donato Traversa, Manuela Schnyder, Janina McKay-Demeler, Georg von Samson-Himmelstjerna, Sandra Mangold-Gehring, Claudia Böhm
Publikováno v:
Parasites & Vectors, Vol 13, Iss 1, Pp 1-10 (2020)
Abstract Background In three randomized, controlled laboratory efficacy studies, the efficacy in the prevention of patent infections of a topical combination of imidacloprid 10%/moxidectin 1% (Advocate® spot-on formulation for cats, Bayer Animal Hea
Externí odkaz:
https://doaj.org/article/a4d8b711ff814998b616a0109151179c
Autor:
Georg von Samson-Himmelstjerna, Katrin Blazejak, Lea Heuer, Donato Traversa, Katrin Deuster, Manuela Schnyder, Matthias Pollmeier, Janina McKay-Demeler, Sandra Mangold-Gehring, Claudia Böhm, Holger Schmidt, Angela Di Cesare, Christina Strube, Gabriele Petry, Roland Schaper
Publikováno v:
Parasites & Vectors
Parasites & Vectors, Vol 13, Iss 1, Pp 1-10 (2020)
Parasites & Vectors, Vol 13, Iss 1, Pp 1-10 (2020)
Background In three randomized, controlled laboratory efficacy studies, the efficacy in the prevention of patent infections of a topical combination of imidacloprid 10%/moxidectin 1% (Advocate® spot-on formulation for cats, Bayer Animal Health GmbH)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::933fa3e5bbfdd70f3ca8d4696eec11d3
http://europepmc.org/articles/PMC7017503
http://europepmc.org/articles/PMC7017503
Autor:
Sina Micus, Cristina Muñoz Abellán, Andreas Moritz, Waldemar Lehmann, Frank Eitner, Sandra Mangold-Gehring, Elke Hartmann, Gerald Beddies
Publikováno v:
Kidney Dis (Basel)
Background: Adenine at 0.75% in the diet (AD) triggers renal impairment in rats. This model of kidney disease is largely reversible when AD feeding is stopped. Testing of novel drugs parallel to AD administration may result in unwanted interference.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e449dfdd2975d619209704c02121bee
https://pubmed.ncbi.nlm.nih.gov/31259175
https://pubmed.ncbi.nlm.nih.gov/31259175